Psychiatr. pro Praxi, 2007; 8(6): 244-246

Psychotropic medication and sleep disorders

MUDr. Zuzana Lattová
Psychiatrická klinika 1. LF UK a VFN Praha

Psychopharmacs cause number of adverse effects considerably affecting quality of life.

Psychopharmacologically induced sleep affection is a merely sharp-sighted adverse effect important for patients. Eventual worsening or development of the restless legs syndrome in psychiatric population, caused by psychopharmacs is discussed. Metabolic syndrome caused by antipsychotics and obstructive sleep apnea, as its newly discussed symptom, is reported.

Keywords: psychopharmacs, psychiatric population, sleep disorders, restless legs syndrome, obstructive sleep apnea

Published: January 15, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lattová Z. Psychotropic medication and sleep disorders. Psychiatr. praxi. 2007;8(6):244-246.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med 2003, 4: 101-119. (A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health). Go to original source... Go to PubMed...
    2. Anticoli-Israel S, Martin J, Jones DW, et al. Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia. Biol Psychiatry 1999, 45: 1426-1432. Go to original source... Go to PubMed...
    3. Bixler EO, Vgontzas AN, Ten Have T et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157: 144-148. Go to original source... Go to PubMed...
    4. Bixler EO, Vgontzas AN, Lin H-M et al. Prevalence of sleep disordered breathing in woman. Am J Respir Crit Care Med 2001; 163: 608-613. Go to original source... Go to PubMed...
    5. Corrigan MH, Denahan AQ, Wright CE et al. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety 2000, 11: 58-65. Go to original source... Go to PubMed...
    6. Dimmitt SB, Riley GJ. Selective serotonine receptors uptake inhibitors can reduce restless legs syndrome (letter). Arch Intern Med 2000, 160: 712. Go to original source... Go to PubMed...
    7. Henning WA. Current guidelines and standarts of practice for restless legs syndrome. Am J Med 2007, 120: 22-27. Go to original source... Go to PubMed...
    8. ICSD2 - International classification of sleep disorders. Diagnostic and coding manual. 2nd. ed. American Academy of Sleep Medicine, 2005.
    9. Lattova Z, Maurovich Horvat E, Nia S et al. Prevalence of restless legs syndrome in psychiatric population. Sleep Biol Rhythms 2007, 5: A185. Go to original source...
    10. Leitliniengruppe der Deutschen Gesellschaft für Neurologie unter Federführung von Claudia Trenkwalder. Leitlinie zur Diagnose und Therapie des Restless-Legs-Syndroms. Stuttgart: Georg Thieme Verlag, 2007.
    11. Michaud M, Dumont M, Selmaoui B et al. Circadian rhythm of restless legs syndrome: a relationship with biological markers. Ann Neurol 2004, 55: 372-380. Go to original source... Go to PubMed...
    12. Newcomer JW Metabolic considerations in the use of antipsychotics medication: a review of recent evidence. J Clin Psychiatry 2007, 68 (suppl 1): 20-27.
    13. Pae CU, Kim TS, Kim JJ et al. Re-administration of mirtazapine could overcome previous mirtazapine-associated restless legs syndrome? Psychiatry Clin Neurosci 2004, 58: 669-670. Go to original source... Go to PubMed...
    14. Park YW, Zhu S, Palaniappan L et al. The metabolic syndome. Prevalence and associated risk factors findings in the US population from the third national health and nutrition examination survey. Arch Int med 2001; 163: 427-443. Go to original source... Go to PubMed...
    15. Peppard PE, Young T, Palta M et al. Prospective study of the association between sleep disorder breathing and hypertension. N Engl J Med 2000; 342: 1378-1384. Go to original source... Go to PubMed...
    16. Picchietti D, Winkelmann JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005, 28: 891-898. Go to PubMed...
    17. Saunamäki T, Jehkonen M. Depression and anxiety in obstructive sleep apnea syndrome: a review. Act Neurol Scand 2007; 116: 277-288. Go to original source... Go to PubMed...
    18. Takahashi KI, Shimizu T, Saito Y et al. Prevalence of sleep-related respiratory disorders in 101 schizophrenic inpatients. Psychiatr Clin Neurosci 1998, 52: 229-231. Go to original source... Go to PubMed...
    19. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005, 9: 211-224. Go to original source... Go to PubMed...
    20. Winkelmann J, Schormair B, Lichtner P et al. Genom-wide association study of restless legs syndrome indentifies common variants in three genomic regions. Nat Genet 2007, 39: 938-939. Go to original source... Go to PubMed...
    21. Zimmermann U, Kraus T, Himmerich H et al. Epidemiology, implications and mechanism underlying drug-induced weight gain in psychiatric patients. J Psych Res 2003, 37: 193-220. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.